Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Sage Therapeutics patents GABA(A) receptor modulators

April 29, 2020

ABBV-951 shows promising safety in patients with Parkinson's disease

April 29, 2020

Sovateltide demonstrates improvement on mRS in acute ischemic stroke trials

April 28, 2020

FIREFISH part 2 study of risdiplam in infants with type 1 SMA meets primary endpoint

April 28, 2020

Roche reports new 6-year data on Ocrevus in MS

April 28, 2020

Genuv studies trametinib in phase I/IIa trial in Korea for ALS

April 28, 2020

New ROMK blockers identified at Bristol-Myers Squibb

April 28, 2020

Pilot study data for ZX-008 as adjunctive therapy in sunflower syndrome

April 28, 2020

Preclinical data support development of FX-301 for post-operative pain

April 28, 2020

FDA approves Ongentys as add-on treatment for patients with Parkinson's disease

April 28, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...